The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.

about

An intronic genetic variation of affects enhancer activity and is associated with glioma susceptibility

P2860

Q57490699-C265D037-E00E-4F12-92D3-E27526949153

P2860

The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.

Item

http://www.wikidata.org/entity/Q42696213

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The MGMT promoter single-nucle ...... MGMT methylated glioblastoma.

@en

The MGMT promoter single-nucle ...... MGMT methylated glioblastoma.

@nl

type

Item

label

The MGMT promoter single-nucle ...... MGMT methylated glioblastoma.

@en

The MGMT promoter single-nucle ...... MGMT methylated glioblastoma.

@nl

prefLabel

The MGMT promoter single-nucle ...... MGMT methylated glioblastoma.

@en

The MGMT promoter single-nucle ...... MGMT methylated glioblastoma.

@nl

P1476

The MGMT promoter single-nucle ...... MGMT methylated glioblastoma.

@en

P2093

Donald Ming-Tak Ho

http://www.w3.org/2001/XMLSchema#string

Hsiang-Ling Ho

http://www.w3.org/2001/XMLSchema#string

Shih-Chieh Lin

http://www.w3.org/2001/XMLSchema#string

Tiffany Dai-Hwa Ho

http://www.w3.org/2001/XMLSchema#string

P2860

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

Polymorphisms in TDG and MGMT genes - epidemiological and functional study in lung cancer patients from Poland

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.

Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations.

The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Inhibition of histone deacetylation potentiates the evolution of acquired temozolomide resistance linked to MGMT upregulation in glioblastoma xenografts.

Influence of promoter/enhancer region haplotypes on MGMT transcriptional regulation: a potential biomarker for human sensitivity to alkylating agents.

MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.

P304

e0186430

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0186430

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chih-Yi Hsu

P577

2017-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29036186

http://www.w3.org/2001/XMLSchema#string

P921

single-nucleotide polymorphism

P932

5643071

http://www.w3.org/2001/XMLSchema#string

The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.

about

P2860

P2860

The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932